Skip to main content
NCBI home page
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
. 1999 May;24(3):227–233.

Effect of lithium maintenance therapy on thyroid and parathyroid function.

M Kusalic 1, F Engelsmann 1
PMCID: PMC1189013  PMID: 10354657

Abstract

OBJECTIVES: To assess changes induced by lithium maintenance therapy on the incidence of thyroid, parathyroid and ion alterations. These were evaluated with respect to the duration of lithium therapy, age, sex, and family history (whether or not the patient had a first-degree relative with thyroid disease). DESIGN: Prospective study. SETTING: Affective Disorders Clinic at St. Mary's Hospital, Montreal. PATIENTS: One hundred and one patients (28 men and 73 women) with bipolar disorder receiving lithium maintenance therapy ranging from 1 year's to 32 years' duration. The control group consisted of 82 patients with no psychiatric or endocrinological diagnoses from the hospital's out-patient clinics. OUTCOME MEASURES: Laboratory analyses of calcium, magnesium and thyroid-stimulating hormone levels performed before beginning lithium therapy and at biannual follow-up. RESULTS: Hypothyroidism developed in 40 patients, excluding 8 patients who were hypothyroid at baseline. All patients having first-degree relatives affected by thyroid illness had accelerated onset of hypothyroidism (3.7 years after onset of lithium therapy) compared with patients without a family history (8.6 years after onset of lithium therapy). Women over 60 years of age were more often affected by hypothyroidism than women under 60 years of age (34.6% versus 31.9%). Magnesium levels in patients on lithium treatment were unchanged from baseline levels. After lithium treatment, calcium levels were higher than either baseline levels or control levels. Thus, lithium treatment counteracted the decrease in plasma calcium levels associated with aging. CONCLUSIONS: Familial thyroid illness is a risk factor for hypothyroidism and hypercalcemia during lithium therapy.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baraban J. M., Worley P. F., Snyder S. H. Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium. Am J Psychiatry. 1989 Oct;146(10):1251–1260. doi: 10.1176/ajp.146.10.1251. [DOI] [PubMed] [Google Scholar]
  2. Bauer M. S., Whybrow P. C., Winokur A. Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch Gen Psychiatry. 1990 May;47(5):427–432. doi: 10.1001/archpsyc.1990.01810170027005. [DOI] [PubMed] [Google Scholar]
  3. Bilous R. W., Tunbridge W. M. The epidemiology of hypothyroidism--an update. Baillieres Clin Endocrinol Metab. 1988 Aug;2(3):531–540. doi: 10.1016/s0950-351x(88)80052-1. [DOI] [PubMed] [Google Scholar]
  4. Birch N. J., Greenfield A. A., Hullin R. P. Lithium therapy and alkaline earth metal metabolism: a biochemical screening study. Psychol Med. 1977 Nov;7(4):613–618. doi: 10.1017/s0033291700006255. [DOI] [PubMed] [Google Scholar]
  5. Burrow G. N., Burke W. R., Himmelhoch J. M., Spencer R. P., Hershman J. M. Effect of lithium on thyroid function. J Clin Endocrinol Metab. 1971 May;32(5):647–652. doi: 10.1210/jcem-32-5-647. [DOI] [PubMed] [Google Scholar]
  6. Christiansen C., Baastrup P. C., Transbøl I. Development of 'primary' hyperparathyroidism during lithium therapy: longitudinal study. Neuropsychobiology. 1980;6(5):280–283. doi: 10.1159/000117770. [DOI] [PubMed] [Google Scholar]
  7. Dousa T. P. Interaction of lithium with vasopressin-sensitive cyclic AMP system of human renal medulla. Endocrinology. 1974 Nov;95(5):1359–1366. doi: 10.1210/endo-95-5-1359. [DOI] [PubMed] [Google Scholar]
  8. Evered D. C., Ormston B. J., Smith P. A., Hall R., Bird T. Grades of hypothyroidism. Br Med J. 1973 Mar 17;1(5854):657–662. doi: 10.1136/bmj.1.5854.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Feinberg M., Steiner M., Carroll B. J. Effects of long-term lithium treatment on serum calcium, magnesium, and calcitonin [proceedings]. Psychopharmacol Bull. 1979 Apr;15(2):81–84. [PubMed] [Google Scholar]
  10. Franks R. D., Dubovsky S. L., Lifshitz M., Coen P., Subryan V., Walker S. H. Long-term lithium carbonate therapy causes hyperparathyroidism. Arch Gen Psychiatry. 1982 Sep;39(9):1074–1077. doi: 10.1001/archpsyc.1982.04290090060012. [DOI] [PubMed] [Google Scholar]
  11. Gewirtz G. R., Malaspina D., Hatterer J. A., Feureisen S., Klein D., Gorman J. M. Occult thyroid dysfunction in patients with refractory depression. Am J Psychiatry. 1988 Aug;145(8):1012–1014. doi: 10.1176/ajp.145.8.1012. [DOI] [PubMed] [Google Scholar]
  12. Haden S. T., Stoll A. L., McCormick S., Scott J., Fuleihan G el-H Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab. 1997 Sep;82(9):2844–2848. doi: 10.1210/jcem.82.9.4218. [DOI] [PubMed] [Google Scholar]
  13. Joffe R. T., Kutcher S., MacDonald C. Thyroid function and bipolar affective disorder. Psychiatry Res. 1988 Aug;25(2):117–121. doi: 10.1016/0165-1781(88)90042-x. [DOI] [PubMed] [Google Scholar]
  14. Krahn D. D. Affective disorder associated with subclinical hypothyroidism. Psychosomatics. 1987 Aug;28(8):440–441. doi: 10.1016/S0033-3182(87)72495-5. [DOI] [PubMed] [Google Scholar]
  15. Kusalic M., Engelsmann F. Effect of lithium maintenance treatment on hypothalamic pituitary gonadal axis in bipolar men. J Psychiatry Neurosci. 1996 May;21(3):181–186. [PMC free article] [PubMed] [Google Scholar]
  16. Kusalic M. Grade II and grade III hypothyroidism in rapid-cycling bipolar patients. Neuropsychobiology. 1992;25(4):177–181. doi: 10.1159/000118833. [DOI] [PubMed] [Google Scholar]
  17. Lazarus J. H., John R., Bennie E. H., Chalmers R. J., Crockett G. Lithium therapy and thyroid function: a long-term study. Psychol Med. 1981 Feb;11(1):85–92. doi: 10.1017/s0033291700053307. [DOI] [PubMed] [Google Scholar]
  18. Manji H. K. G proteins: implications for psychiatry. Am J Psychiatry. 1992 Jun;149(6):746–760. doi: 10.1176/ajp.149.6.746. [DOI] [PubMed] [Google Scholar]
  19. Piziak V. K., Sellman J. E., Othmer E. Lithium and hypothyroidism. J Clin Psychiatry. 1978 Sep;39(9):709–711. [PubMed] [Google Scholar]
  20. Price L. H., Charney D. S., Delgado P. L., Heninger G. R. Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder. Arch Gen Psychiatry. 1989 Jan;46(1):13–19. doi: 10.1001/archpsyc.1989.01810010015002. [DOI] [PubMed] [Google Scholar]
  21. Sawin C. T., Castelli W. P., Hershman J. M., McNamara P., Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med. 1985 Aug;145(8):1386–1388. [PubMed] [Google Scholar]
  22. Shen F. H., Sherrard D. J. Lithium-induced hyperparathyroidism: an alteration of the "set-point". Ann Intern Med. 1982 Jan;96(1):63–65. doi: 10.7326/0003-4819-96-1-63. [DOI] [PubMed] [Google Scholar]
  23. Spaulding S. W., Burrow G. N., Ramey J. N., Donabedian R. K. Effect of increased iodide intake on thyroid function in subjects on chronic lithium therapy. Acta Endocrinol (Copenh) 1977 Feb;84(2):290–296. doi: 10.1530/acta.0.0840290. [DOI] [PubMed] [Google Scholar]
  24. Stancer H. C., Forbath N. Hyperparathyroidism, hypothyroidism, and impaired renal function after 10 to 20 years of lithium treatment. Arch Intern Med. 1989 May;149(5):1042–1045. [PubMed] [Google Scholar]
  25. Tapp A. Affective cycling in thyroid disease. J Clin Psychiatry. 1988 May;49(5):199–200. [PubMed] [Google Scholar]
  26. Tunbridge W. M., Evered D. C., Hall R., Appleton D., Brewis M., Clark F., Evans J. G., Young E., Bird T., Smith P. A. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977 Dec;7(6):481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x. [DOI] [PubMed] [Google Scholar]
  27. Waller D. G., Albano J. D., Millar J. G., Polak A. Cyclic AMP responses to parathyroid hormone and glucagon during lithium treatment. Clin Sci (Lond) 1984 May;66(5):557–559. doi: 10.1042/cs0660557. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Science Publishing

RESOURCES